Aventis Pharms, Inc. et al. v. Barr Labs, Inc. et al.

(01-3627-JAG) (D NJ). Patent infringement action regarding Barr Laboratories’ ANDA for Aventis’s allergy product Allegra® (fexofenadine hydrochloride). Successful opposition to preliminary injunction and successful launch at risk for Barr.

View All Results
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.